# RIN1

## Overview
RIN1 (Ras and Rab interactor 1) is a gene that encodes a multifunctional protein involved in various cellular processes, including signal transduction, endocytosis, and cytoskeletal remodeling. The RIN1 protein is characterized as a guanine nucleotide exchange factor (GEF) and contains several functional domains, such as the SRC homology 2 (SH2) domain, proline-rich domains, and a Ras association (RA) domain, which facilitate its interactions with other proteins like Abl tyrosine kinases and EphA4 receptors (Deininger2008The; Ziegler2011A). RIN1 plays a significant role in RAS-mediated signaling pathways by interacting with activated RAS proteins and acting as an activator of ABL tyrosine kinases, which are crucial for processes like cell migration and synaptic plasticity (Hu2005RIN1; Han1997Protein). The protein is predominantly expressed in forebrain neurons, where it influences memory formation and synaptic plasticity, particularly in the hippocampus and amygdala (Dhaka2003The). Additionally, alterations in RIN1 expression have been linked to various cancers, including leukemia and breast cancer, highlighting its clinical significance in oncogenesis and potential as a therapeutic target (Thai2010ABL; Zhang2020Role).

## Structure
RIN1 (Ras and Rab interactor 1) is a protein characterized by several functional domains that contribute to its role in signal transduction. The amino-terminal half of RIN1 contains a SRC homology 2 (SH2) domain and proline-rich domains, which are important for interactions with other proteins, such as Abl tyrosine kinases and EphA4 receptors (Deininger2008The; Ziegler2011A). The carboxyl-terminal section includes a Ras association (RA) domain and a guanine nucleotide exchange factor (GEF) domain, which is related to the vacuolar protein sorting 9 (VPS9) domain, crucial for its GEF activity for Rab5 (Ziegler2011A; Han1997Protein).

RIN1 is involved in the endocytosis of receptor tyrosine kinases like EGFR and EphA4, facilitated by its GEF activity for Rab5 (Deininger2008The; Ziegler2011A). The protein undergoes post-translational modifications, such as phosphorylation by Abl kinases, which is important for its function in cell migration and interaction with other proteins (Hu2005RIN1; Ziegler2011A). RIN1 also exists in different isoforms due to alternative splicing, which may affect its interaction capabilities and functional roles (Han1997Protein).

## Function
RIN1 (Ras and Rab interactor 1) is a protein that plays a significant role in signal transduction pathways in healthy human cells. It interacts with activated RAS proteins, suggesting its involvement in RAS-mediated signaling pathways. RIN1 binds to the effector domain of RAS in a GTP-dependent manner, similar to RAF1, a known RAS effector, indicating its role in pathways activated by RAS (Han1995A; Han1997Protein). RIN1 also interacts with 14-3-3 proteins, which are involved in facilitating protein interactions and potentially activating signaling pathways (Han1997Protein).

RIN1 is an activator of ABL tyrosine kinases, enhancing the phosphorylation of CRKL, a substrate of ABL kinase, and is involved in cytoskeletal remodeling and cell migration, essential processes in development and wound healing (Hu2005RIN1). It acts as a conduit for signal transduction from RAS to ABL proteins, forming a complex with HRAS and ABL2 (Hu2005RIN1). RIN1's role in cell migration is confirmed through siRNA-mediated knockdown experiments, which show reduced CRKL phosphorylation and blocked migration in mammary epithelial cells (Hu2005RIN1).

In the brain, RIN1 is expressed predominantly in forebrain neurons, particularly in the hippocampus and amygdala, where it modulates synaptic plasticity and memory formation (Dhaka2003The). RIN1 acts as a negative regulator of synaptic plasticity in the amygdala, influencing the formation of aversive memories (Dhaka2003The).

## Clinical Significance
Alterations in the expression and function of the RIN1 gene have been implicated in various cancers. In leukemia, RIN1 plays a critical role in the activity of ABL fusion oncogenes, such as BCR-ABL1, which are involved in chronic myeloid leukemia (CML) and acute lymphocytic leukemia (ALL). Overexpression of RIN1 enhances the kinase activity of BCR-ABL1, contributing to leukemogenesis. Conversely, silencing RIN1 increases sensitivity to the ABL kinase inhibitor imatinib, suggesting that targeting RIN1 could be a therapeutic strategy for imatinib-resistant leukemias (Thai2010ABL).

In head and neck tumors, RIN1 expression is significantly lower in both malignant and benign tissues compared to normal controls. This reduced expression is associated with age in malignant cases, indicating a potential role in tumor progression (Osei2024Expression).

In breast cancer, RIN1 expression affects telomerase activity and cell proliferation. It has been shown to inhibit telomerase activity in breast cancer cells, impacting cell proliferation through EGF-Ras mediated signaling pathways. Alterations in RIN1 expression or mutations can influence these pathways, potentially affecting cancer progression (Zhang2020Role).

## Interactions
RIN1 (Ras and Rab interactor 1) is involved in several protein interactions that influence signal transduction pathways. It directly interacts with activated Ras proteins, such as yeast Ras2p and human H-Ras, with a preference for the GTP-bound form of Ras. This interaction is similar to that of known Ras effectors like Raf1, although RIN1 does not bind to effector or dominant negative mutants of H-Ras (Han1995A; Han1997Protein). RIN1 competes with Raf1 for binding to H-Ras, suggesting a regulatory role in Ras signaling (Dhaka2003The).

RIN1 also interacts with 14-3-3 proteins, which are involved in mitogenesis and oncogenic transformation. This interaction is mediated by the RAS-binding domain of RIN1 and is essential for its function in signal transduction (Han1997Protein). Additionally, RIN1 binds to the tyrosine kinase c-ABL, serving as a substrate for tyrosine phosphorylation. This interaction involves a proline-rich sequence within RIN1 that binds to the SH3 domain of c-ABL (Han1997Protein).

RIN1 is also implicated in enhancing BCR-ABL1 kinase activity, which is relevant in the context of leukemia. It binds to the SH3 and SH2 domains of ABL, modulating kinase activity and potentially contributing to drug resistance (Thai2010ABL).


## References


[1. (Thai2010ABL) M Thai, P Y Ting, J McLaughlin, D Cheng, M Müschen, O N Witte, and J Colicelli. Abl fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator rin1. Leukemia, 25(2):290–300, November 2010. URL: http://dx.doi.org/10.1038/leu.2010.268, doi:10.1038/leu.2010.268. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/leu.2010.268)

[2. (Han1995A) Limin Han and John Colicelli. A human protein selected for interference with ras function interacts directly with ras and competes with raf1. Molecular and Cellular Biology, 15(3):1318–1323, March 1995. URL: http://dx.doi.org/10.1128/MCB.15.3.1318, doi:10.1128/mcb.15.3.1318. This article has 236 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.15.3.1318)

[3. (Dhaka2003The) Ajay Dhaka, Rui M. Costa, Hailiang Hu, Dwain K. Irvin, Apoor Patel, Harley I. Kornblum, Alcino J. Silva, Thomas J. O’Dell, and John Colicelli. The ras effector rin1 modulates the formation of aversive memories. The Journal of Neuroscience, 23(3):748–757, February 2003. URL: http://dx.doi.org/10.1523/JNEUROSCI.23-03-00748.2003, doi:10.1523/jneurosci.23-03-00748.2003. This article has 95 citations.](https://doi.org/10.1523/JNEUROSCI.23-03-00748.2003)

[4. (Hu2005RIN1) Hailiang Hu, Joanne M. Bliss, Ying Wang, and John Colicelli. Rin1 is an abl tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Current Biology, 15(9):815–823, May 2005. URL: http://dx.doi.org/10.1016/j.cub.2005.03.049, doi:10.1016/j.cub.2005.03.049. This article has 105 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cub.2005.03.049)

[5. (Zhang2020Role) W. Zhang, M.L. Veisaga, and M.A. Barbieri. Role of rin1 on telomerase activity driven by egf-ras mediated signaling in breast cancer. Experimental Cell Research, 396(2):112318, November 2020. URL: http://dx.doi.org/10.1016/j.yexcr.2020.112318, doi:10.1016/j.yexcr.2020.112318. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2020.112318)

[6. (Han1997Protein) Limin Han, Derrick Wong, Ajay Dhaka, Daniel Afar, Michael White, Wielin Xie, Harvey Herschman, Owen Witte, and John Colicelli. Protein binding and signaling properties of rin1 suggest a unique effector function. Proceedings of the National Academy of Sciences, 94(10):4954–4959, May 1997. URL: http://dx.doi.org/10.1073/pnas.94.10.4954, doi:10.1073/pnas.94.10.4954. This article has 93 citations.](https://doi.org/10.1073/pnas.94.10.4954)

[7. (Deininger2008The) Katrin Deininger, Matthias Eder, Edgar R. Kramer, Walter Zieglgänsberger, Hans-Ulrich Dodt, Klaus Dornmair, John Colicelli, and Rüdiger Klein. The rab5 guanylate exchange factor rin1 regulates endocytosis of the epha4 receptor in mature excitatory neurons. Proceedings of the National Academy of Sciences, 105(34):12539–12544, August 2008. URL: http://dx.doi.org/10.1073/pnas.0801174105, doi:10.1073/pnas.0801174105. This article has 63 citations.](https://doi.org/10.1073/pnas.0801174105)

[8. (Ziegler2011A) Susanne Ziegler, Tim Eiseler, Rolf-Peter Scholz, Alexander Beck, Gisela Link, and Angelika Hausser. A novel protein kinase d phosphorylation site in the tumor suppressor rab interactor 1 is critical for coordination of cell migration. Molecular Biology of the Cell, 22(5):570–580, March 2011. URL: http://dx.doi.org/10.1091/mbc.e10-05-0427, doi:10.1091/mbc.e10-05-0427. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e10-05-0427)

[9. (Osei2024Expression) Roland Osei Saahene, Precious Barnes, F. A. Yeboah, Elvis Agbo, Du-Bois Asante, and Samuel Kofi Arhin. Expression of ras and rab interactor 1 (rin1) in head and neck tumors at selected hospital in ghana. PLOS ONE, 19(4):e0301295, April 2024. URL: http://dx.doi.org/10.1371/journal.pone.0301295, doi:10.1371/journal.pone.0301295. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0301295)